The global diamond-blackfan anaemia (DBAAASE) syndrome therapeutics market is expected to exceed a valuation of US$ 4.8 billion in 2023, with a CAGR of 4.2% from 2023 to 2033. By the end of the aforementioned assessment period, the market is expected to be valued at US$ 7.29 billion. Diamond-blackfan anaemia is an inherited blood disorder …